What is the SUGAMMADEX?

SUGAMMADEX is , while it's Molecular Formula is C72H112O48S8. 6A,6B,6C,6D,6E,6F,6G,6H-octakis-S-(2-carboxyethyl)-6A,6B,6C,6D,6E,6F,6G,6H-octathio-γ-Cyclodextrin, also known as Sugammadex, is used to reverse postoperative residual neuromuscular blockade.

What is the CAS number for SUGAMMADEX?

The CAS number of SUGAMMADEX is 343306-71-8.

What is SUGAMMADEX (343306-71-8) used for?

Sugammadex is a selective relaxant binding agent indicated for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide during surgery in adults. Rocuronium bromide and vecuronium bromide are neuromuscular blocking medications that cause temporary paralysis and are especially useful for general anesthesia, ventilation, or tracheal intubation that patients may require for surgery. Sugammadex provides a new treatment option to reverse the effects of those medications and possibly help patients recover sooner post-surgery. Sugammadex (brand name Bridion) is marketed by Merck Sharp and Dohme, and was approved by the United States FDA on December 15, 2015.

What is the SUGAMMADEX?

SUGAMMADEX is , while it's Molecular Formula is C72H112O48S8. 6A,6B,6C,6D,6E,6F,6G,6H-octakis-S-(2-carboxyethyl)-6A,6B,6C,6D,6E,6F,6G,6H-octathio-γ-Cyclodextrin, also known as Sugammadex, is used to reverse postoperative residual neuromuscular blockade.

What is the CAS number for SUGAMMADEX?

The CAS number of SUGAMMADEX is 343306-71-8.

What is SUGAMMADEX (343306-71-8) used for?

Sugammadex is a selective relaxant binding agent indicated for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide during surgery in adults. Rocuronium bromide and vecuronium bromide are neuromuscular blocking medications that cause temporary paralysis and are especially useful for general anesthesia, ventilation, or tracheal intubation that patients may require for surgery. Sugammadex provides a new treatment option to reverse the effects of those medications and possibly help patients recover sooner post-surgery. Sugammadex (brand name Bridion) is marketed by Merck Sharp and Dohme, and was approved by the United States FDA on December 15, 2015.

Cost-effective and customizable Sugammadex Sodium 343306-71-8 in stock

Product NameSugammadex Sodium
CasNo. 343306-71-8
MFC72H112O48S8
MW2178.01
Purity
Appearance
Packing
Contact usInquiry

Product Details

CasNo： 343306-71-8

MF： C72H112O48S8